World's Best Scientists 2026 revealed!
Tatsuya Atsumi

Tatsuya Atsumi

D-Index & Metrics

Immunology

D-Index
76
Citations
29539
World Ranking
1865
National Ranking
71

Overview

Tatsuya Atsumi is affiliated with Hokkaido University in Japan and has contributed extensively to the field of medicine with a particular focus on rheumatology, endocrinology, diabetes, metabolism, genetics, surgery, and pulmonary and respiratory medicine. Their research spans multiple subfields, reflecting a broad expertise within clinical and biomedical sciences.

Their work encompasses a range of topics including systemic lupus erythematosus research, rheumatoid arthritis research and therapies, diabetes treatment and management, pancreatic function and diabetes, vasculitis and related conditions, metabolism, diabetes, and cancer, as well as systemic sclerosis and related diseases.

Among the recent publications associated with or relevant to Atsumi's research environment, the following notable papers are highlighted:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, 2023, Arthritis & Rheumatology
  • 2023 ACR/EULAR antiphospholipid syndrome classification criteria, 2023, Annals of the Rheumatic Diseases
  • Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis, 2021, JAMA
  • Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial, 2021, Annals of the Rheumatic Diseases

Atsumi has collaborated frequently with scholars such as Akinobu Nakamura, Hiraku Kameda, Hiroshi Nomoto, Kyu Yong Cho, and Hideaki Miyoshi, with these coauthors appearing respectively 87, 83, 78, 65, and 65 times in shared publications. This indicates a robust research network within the medical research community in Japan and internationally.

Publication venues where Atsumi's work or closely related work appears commonly include Modern Rheumatology, Annals of the Rheumatic Diseases, Diabetes, Journal of the Endocrine Society, and Lara D. Veeken, with counts of 32, 28, 22, 20, and 14 publications respectively. This reflects engagement with high-impact journals focusing on rheumatology, diabetes, and endocrinology.

The main research field for Atsumi is medicine, with 724 publications, underscoring a significant contribution to health sciences research. Within this broad field, particular emphasis on rheumatology with 139 publications highlights a specialized focus area.

Best Publications

  • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

    S. Miyakis;M. D. Lockshin;T. Atsumi;D. W. Branch

  • ANTIPHOSPHOLIPID ANTIBODIES AFFECT TROPHOBLAST GONADOTROPIN SECRETION AND INVASIVENESS BY BINDING DIRECTLY AND THROUGH ADHERED β2-GLYCOPROTEIN I

    N Di Simone;P L Meroni;N Del Papa;E Raschi

  • Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    Désirée van der Heijde;James Cheng-Chung Wei;Maxime Dougados;Philip Mease

  • Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases

    S Fukaya;S Yasuda;T Hashimoto;K Oku

  • Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.

    Tatsuya Atsumi;Masahiro Ieko;Maria L. Bertolaccini;Kenji Ichikawa

  • The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome

    Olga Amengual;Tatsuya Atsumi;Munther A. Khamashta;Graham R. V. Hughes

  • Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events

    Kotaro Otomo;Tatsuya Atsumi;Olga Amengual;Yuichiro Fujieda

  • Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA–Associated Microscopic Polyangiitis

    Daigo Nakazawa;Haruki Shida;Utano Tomaru;Masaharu Yoshida

  • Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients:

    N. M. Shah;M. A. Khamashta;T. Atsumi;G. R. V. Hughes

  • 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

    Maria Laura Bertolaccini;Olga Amengual;Laura Andreoli;Tatsuya Atsumi

  • Circulating oxidized LDL forms complexes with β2-glycoprotein I implication as an atherogenic autoantigen

    Kazuko Kobayashi;Makoto Kishi;Tatsuya Atsumi;Maria L. Bertolaccini

  • Complement activation in patients with primary antiphospholipid syndrome

    Kenji Oku;Tatsuya Atsumi;Miyuki Bohgaki;Olga Amengual

  • Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH

    Katrien Devreese;SS Pierangeli;B De Laat;A Tripodi

  • Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome.

    O. Amengual;T. Atsumi;M. A. Khamashta;T. Koike

  • The responses of macrophages in interaction with neutrophils that undergo NETosis.

    Daigo Nakazawa;Haruki Shida;Yoshihiro Kusunoki;Arina Miyoshi

  • The Phenotype of Infiltrating Macrophages Influences Arteriosclerotic Plaque Vulnerability in the Carotid Artery

    Kyu Yong Cho;Hideaki Miyoshi;Satoshi Kuroda;Hiroshi Yasuda

  • Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety

    Yukiko Komano;Michi Tanaka;Toshihiro Nanki;Ryuji Koike

  • A specific ligand for β2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages

    Kazuko Kobayashi;Eiji Matsuura;Qingping Liu;Jun Ichi Furukawa

  • Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population

    Y. Takizawa;S. Inokuma;Y. Tanaka;K. Saito

  • The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis

    Takashi Kurita;Shinsuke Yasuda;Koji Oba;Toshio Odani

  • The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2Glycoprotein I antibodies

    Miyuki Bohgaki;Tatsuya Atsumi;Yumi Yamashita;Shinsuke Yasuda

Frequent Co-Authors

Takao Koike
Takao Koike Hokkaido University
Munther A. Khamashta
Munther A. Khamashta King's College London
Yoshiya Tanaka
Yoshiya Tanaka University of Occupational and Environmental Health Japan
Tsutomu Takeuchi
Tsutomu Takeuchi Keio University
Yasuo Terauchi
Yasuo Terauchi Yokohama City University
Eiji Matsuura
Eiji Matsuura Okayama University
Nobuyuki Miyasaka
Nobuyuki Miyasaka Tokyo Medical and Dental University
Yoshinari Takasaki
Yoshinari Takasaki Juntendo University
Graham R. V. Hughes
Graham R. V. Hughes London Bridge Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related healthcare degrees can open diverse career avenues. Many professionals transition within nursing specialties, such as moving from Family Nurse Practitioner (FNP) roles to more specialized fields. Understanding how to fnp to acute care np can be crucial for those aiming to work in critical care settings with immunological patients.

Accelerated programs offer a fast track to nursing roles. For example, nurses can explore accelerated fnp programs to advance their practice swiftly. Similarly, individuals without a nursing background can enter the field through well-designed online courses, making the best online rn programs for non nurses an excellent starting point.

For those seeking expedited nursing education, identifying the easiest absn program to get into can help in earning a Bachelor of Science in Nursing efficiently. Such programs often provide the flexibility and support needed for busy students.

Overall, these pathways complement Immunology studies by preparing graduates for impactful healthcare roles, enhancing their ability to apply immunological knowledge in clinical practice.

Best Scientists Citing Tatsuya Atsumi

Trending Scientists